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Abstract 
Coronary emboli causing ST elevation myocardial infarction (STEMI) is a rare condition. Intracardiac 
thrombus generated by valvular disease is the most common source of intracoronary embolism 
and mitral stenosis is frequently affected by intraatrial thrombus. Therapeutic strategy of coronary 
embolism is challenging because there were still no recommendation regarding coronary 
embolism published to day. We reported A 25 years old woman was admitted to the emergency 
department because of STEMI with complication of acute pulmonary edema and cardiogenic 
shock, and recurrent cardiac arrest. Angiographically showed total occlusion of left main artery 
with thrombotic lesions. Unfortunately after unfractionated heparin (UFH) was given and performed 
catheter cannulation, thrombus run to distal part of left coconary artery. Procedure is stopped 
and then patient transferred to cardiac care unit, but death shortly after arrival. Transthroracic 
echocardiography revealed mild to mild-modertae mitral stenosis with severe regurgitation due to 
mitral valve prolaps, aortic regurgitation, and left atrial and ventricular dilatation with no thrombus 
or spontaneous echo contrast, and failed to fi nd thrombus with in atrium. The presence af atrial 
dilatation and aortic regurgitation increased risk of thrombosis, meanwhile mitral regurgitation were 
reported as protective factor of atrial thrombosis. The pathophysiology of arterial thrombus or white 
thrombus involving platelet activation leads to double antiplatelets and GbIIb/IIIa inhibitior to be 
more cruciale in coronary embolism. Double antiplatelet dan UFH administration did not improve 
survival in these patients. So that further research was needed to make a consensus of therapy. 
Careful assessment of intracardiac thrombus and risk of thromboembolism were important to 
prevent systemic embolization.
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Introduction
Atherosclerosis plaque rupture followed 
by thrombus formation is the main cause of 
acute myocardial infarction (AMI). Nevertheless, 
about 7% of patients who underwent coronary 
ang iography have no nar rowing o f  the 
atherosclerosis disease1.
Coronary embolism is a cause of non-
atherosclerosis AMI. Prizel et al. (1978) reported 
incidence of coronary embolism about 13% in 
autopsy study of 419 AMI patients, which main 
cause is valvular heart disease (40%), atrial 
fibrillation (AF) (24%), and cardiomyopathy 
(20%)2. 
Before 1960, coronary embolism more 
caused by infective endocaditis. Nevertheless, 
according to antibiotic development, recently it 
more caused by valvular heart disease such as 
mitral and aortic valve disease, AF, or in patients 
with prosthetic valve implantation2.
Embolism that come from heart usually 
originate from thrombus within left ventricle, 
heart tumor such as myxoma, dilatation of left 
atrium (LA), or paradoxical embolism come 
from patent with foramen ovale. Calcifi cation of 
mitral anulus as well as mitra valve prolaps were 
also associated with systemic embolism event, 
although remains controversial3. Mitral stenosis 
(MS) is most common valvular heart disease that 
causes thrombus formation  within LA4, although 
very rare resulted in coronary embolism5.
In the following I want to presentate a young 
female patients 25 years old came to my hospital 
with STEMI and previous mild-modertae mitral 
stenosis and severe mitral rugurgitation.
Case Illustration
A young female 25 years old came to the 
hospital with chief complain of chest pain since 
2 hours ago, when she was taking arrest. Her 
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tenderness chest pain has suffered more than 
20 minute, accompanies with cold sweating and 
short of breath, no pain radiation, palpitation and 
fever. 
No history of injury, previous surgery, 
hypertension and diabetes mellitus. Otherwise, 
there was a hisory of smoking about lebih 1-2 pack 
a day. No history of hormonal contraception, leg 
edema or vein thrombosis and renal disease. No 
family history of coronary artery disease (CAD). 
Th is  pa t ien t  compla in ing  dyspnoe 
on effort since 3 months ago. Trans thoracal 
echocardiography showed LA and LV dilatation, 
LV ejection fraction 57%, normokinetic, diastolic 
dysfunction pseudonormal type, mild-modertae 
mitral stenosis and severe mitral regurgitation due 
to anterior mitral valve prolaps. She routinely was 
administered digoxin 1x 0,125 mg, candesartan 
2x40 mg, and furosemid 1x20 mg, and had planned 
to be performed mitral walve replacement.
On physical examination demonstrated her 
general condition bad, look short of breath and 
stupor. Blood pressure not measurable, respiration 
rate  36 x/ minute, pulse 100 x/ minute regular, no 
fever. There is no anemia and jaundice. Jugular 
vein pressure was 5+4 cm H2O. There was 
cardiomegaly with touchable apex in V intercostal 
space 1 finger left lateral midclavicularis line. 
Cardiac auscultation showed normal S1 and S2 
heart sounds, the degree of pan-systolic murmur 
encountered 3/6 with punctum maximum in the 
apex and radiating to the axilla. There was no 
additional murmur. Lung examination found normal 
vesicular sounds, crackles at the bottom of both 
lungs. Abdominal examination within normal limits, 
and there was no peripheral edema.
Electrocardiography (Figure 1) showed sinus 
rhythm with a heart rate of 68 x / min. Intermediate 
axis, with ST segment elevation in leads V4-
V6, I, and aVL. Based on the results of history, 
physical examination, and ECG, patients clinically 
diagnosed as high lateral and anterolateral STEMI 
onset 2 hours, Killip IV, TIMI risk 9/14 score, 
and Grace scores 233, in chronic heart failure 
with dilated left atrium and ventricle due to mild-
modertae mitral stenosis and severe mitral valve 
regurgitation because of mitral valve prolapse.
Patients present with cardiogenic shock and 
acute pulmonary edema, and then the patient was 
given 40 mg of furosemide injection and inotropic 
support with dopamine to noradrenaline, and 
loading with dual antiplatelet. But the shock is 
not improved, the ECG monitor showed total AV 
block (Figure 2). Two hours later the patient fell in 
a state of pulseless electrical activity (PEA) and 
then performed cardiopulmonary resuscitation and 
intubation. After cardiac resuscitation performed 
for approximately 1-2 hours, patients got ROSC 
(return of spontaneous circulation) with ECG still 
showed ST segment elevation and blood pressure 
90/60 mmHg. Patients were then planned to do 
coronary angiography immediately.
Laboratory results showed a hemoglobin 
level 11.9 g / dL; leukocyte count 23 rb / mmc; 
platelets 295 rb / mmc; hematocrit 36.7; blood urea 
nitrogen 9 mg / dl; creatinine 1.38 mg / dl; AST 63; 
ALT 51; albumin 4.2 g / dL, sodium 139; potassium 
3.6; chloride 99. Cardiac enzymes performed 6 
hours after the onset of chest pain showed CKMB 
119, Troponin I 1.57.
ECG on admision 
 
FIGURE 2. Total AV block seen on ECG monitor.
FIGURE 1.  Electrocardiographic (ECG) showed 
sinus rhythm with a heart rate of 68 x / 
min with ST-segment elevation in leads 
V4-V6, I, and aVL.
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FIGURE 3. Angiography in the LAO-cranial view 30/0 showed normal RCA, the origin 
comes from the non-coronary sinus valvasa.
FIGURE 4. Angiography in the LAO-cranial view 30/0 (A) and LAO-caudal view 45/35 (B), 
thrombotic lesions seen in the distal left main artery (white arrow).
FIGURE 5. Angiography in RAO-caudal view 20/20 looks thrombus (arrow) running from the 
proximal (A) to the distal LAD and LCX (B). Left main artery anatomy looks after the 
release of thrombus, atherosclerotic lesions not visible (arrow heads).
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After a temporary pacemaker (TPM) inserted, 
then performed coronary angiography. Cannulation 
of the right coronary artery (RCA) can not be done, 
so it was decided to do aortic angiography. Aortic 
angiography showed normal RCA, with origin from 
valvasa non-coronary sinus (Figure 3). Figure 4 
showed total occlusion of the distal left main artery 
(LM), with thrombotic lesions.
Then the patient is given heparin and 
performed left coronary artery cannulation. 
However, when injected contrast, thrombus off 
toward the distal LAD and LCX. Based on the 
results of coronary angiography, there was also 
not found atherosclerotic lesions of LM (Figure 
5). During coronary angiography, patients fell into 
cardiac arrest condition two times. Patient then 
transferred to the cardiac intensive care (ICCU). 
However when the patient arrives in ICCU, she 
returned cardiac arrest and performed CPR, but 
no response and the patient died.
According to the evaluation results of 
transthoracic echocardiography (TTE) 3 months 
ago, found severe mitral valve regurgitation and 
mild-moderate mitral stenosis with a mean gradient 
of 9.5 mmHg and a peak gradient of 19 mmHg, 
mitral valve area of  2.3 cm2. Left atrial diameter of 
57 mm (Figure 6). Presence of aortic regurgitation 
on aortic angiography (does not seem clear on 
TTE) can lead to underestimate of MVA value in 
these patients.
Discussion
Patient in this case was a young woman 
aged 25 years with no obvious risk factors for 
atherosclerosis except history of smoking. Osula 
et al.6 generally halve the IMA at a young age into 
the coronary arteries “normal” and “abnormal” 
on coronary angiography. Coronary arteries are 
“normal” include thrombosis, embolism, spasm, 
or a combination. While the “abnormal” may be 
premature atherosclerosis, spontaneous coronary 
dissection, aneurysm, ectasia, or anomalous origin 
of the coronary arteries. The presence of thrombus 
in the LM and the absence of atherosclerotic 
lesions, the etiology of this case is thrombosis or 
embolism.
Coronary artery thrombus in situ of the 
two cases reported, caused by a defi ciency of 
antithrombin, protein C, or protein S 7, 8. However 
this is a very rare occurrence, because, although 
these factors were strong for the occurrence of 
venous thrombosis, but no effect on arterial or 
very small 9. No history of deep vein thrombosis, 
or thromboembolic events in these patients and 
her families also support that the etiology of 
coronary thrombus in these patients is not due 
to factors such hypercoagulability. Therefore, 
coronary embolism originating from the heart 
valve disease such as mitral stenosis with 
regurgitation most likely the cause of AMI in 
these patients.
Coronary embolism of the case reported is a 
rare disease, because the ostium of the coronary 
artery is located behind the aortic valve cusps and 
the presence of heavy systolic ejection of the left 
ventricle. Etiology of coronary embolism commonly 
associated with valvular heart disease, the use 
of prosthetic valve, infective endocarditis, dilated 
cardiomyopathy, and arrhythmias5. Paradoxical 
FIGURE 7. TTE apical four chambers position, 
which seemed to indicate a mosaic fl ow 
turbulence while diastolic transmitral fl ow 
that normally occur in mitral stenosis 
with a mean gradient of 9.5 mmHg MV.
FIGURE 6. TTE parasternal long axis position 
while diastolic (left) and systolic (right), 
where the anatomy of the mitral valve 
posterior leafl eat (PML) seemed stiff, 
with prolapse of the anterior mitral 
leafl eat (AML), but not the typical hockey 
stick picture appearance like in mitral 
stenosis caused by rheumatic disease.
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embolism can also occur as a result of venous 
thrombosis in atrial septal defect 10. 
Coronary embolism of intracardiac thrombus 
may originate from the atria or the ventricles due 
to stasis of blood fl ow. Intraventricular thrombus 
generally caused ventricular aneurysm, severe 
LV systolic dysfunction, or kinetic disorders4. All-
cause ventricular stasis is not found in this case. 
While the factors predisposing to thrombus was 
intraatrial atrial enlargement, mitral valve disease 
and atrial fi brillation which causes low blood fl ow 
in the left atrium. The highest incidence of left 
atrial thrombus is a rheumatic mitral stenosis and 
atrial fi brillation4. 
Mitral stenosis associated with increased 
left atrial coagulation activity, thus increasing 
the incidence of intracardiac thrombus, although 
patients with sinus rhythm but found left atrial 
spontaneous echo contrast (LASEC). Atrial 
fi brillation increases the risk of thromboembolism 
2-7 times 11. The incidence of systemic embolism 
in mitral stenosis was 9.1% in patients with sinus 
rhythm for 3 years. Based ECG of this case, heart 
rhythm is still sinus rhythm despite the possibility of 
the occurrence of atrial fi brillation are not detected, 
as reported by Samol et al.12 who reported 
prevalence in risk groups by 5.3%.
The age factors associated with increased 
risk of embolism (relative risk [RR] 1.12 [95% CI 
1.04 to 1.21]). Similarly, the presence of thrombus 
(RR 37.1 [CI 2.82 to 487.8]), the severity of mitral 
stenosis (RR 16.9 [CI 1.53 to 187.0]), and the 
presence of aortic regurgitation (RR 22 , 4 [CI 
2.72 to 184.8]) associated with an increased 
risk of embolism14. While the presence of mitral 
regurgitation is associated with a protective factor 
(OR 0.39) occurrence of thrombus because 
regurgitant fl ow lead no stasis in the left atrium 
4,15. In fact, the degree of mitral regurgitation 
especially severe is also a protective factor against 
the incidence of ventricular thrombus in dilated 
cardiomyopathy patients because it increases 
blood flow in the ventricular apex16. However, 
study Tse et al.17 mention that mitral regurgitation 
associated with systemic platelet activity, who 
may be associated with thromboembolic events. 
Protective effects in patients with rheumatic mitral 
regurgitation also be reduced if left atrial diameter 
is more than 60 mm18.
In these patients the dominance of the valve 
abnormality is mitral regurgitation than stenosis, 
and the results of TTE, not clearly found LASEC 
or thrombus. However, the TTE examination has a 
low sensitivity (53-63%), so the TEE examination 
(sensitivity 99%) should be performed in these 
patients 4.
Age was associated with an increased risk 
of thrombosis exponentially. Mechanisms thought 
to be caused by the cumulative effect of factors 
of blood vessel walls, decreased physical activity, 
and increased activity of several coagulation 
factors such as factor V, VII, VIII, IX, and fi brinogen 
9. However, the patient is is still young 25 years old, 
so the risk for thromboembolism is small.
Currently, there are no clear recommendations 
about the management of coronary embolism. Raj 
and Singh19 reported, a woman 23 years after double 
valve replacement with infarction, and performed with 
streptokinase thrombolytic followed by administration 
of an anticoagulant, ACE inhibitors, and antiplatelet. 
The result of the evaluation of coronary angiography 
showed normal.
Thrombolysis in coronary embolism caused 
by infective endocarditis should be avoided 
because of the risk of cerebral embolism 20 or 
brain and systemic hemorrhage 21. Dual antiplatelet 
therapy and intravenous heparin is used in cases 
of coronary embolism with mitral stenosis 5 and in 
cases with atrial fi brillation 20.
Antiplatelet in case with prosthetic valve 
serves improve platelet survival and reduce the 
risk of thromboembolism when combined with 
anticoagulants13. Antiplatelet also associated with 
the prevention of platelet adhesion and activation 
in arterial thrombosis or intracardiac thrombus 
22,23. However the role of antiplatelet therapy in 
coronary embolism due to intracardiac thrombus 
needs further research.
If the intervention is done, then several 
methods such as Forgaty maneuver, sole balloon 
angioplasty, stenting or thrombus aspiration can be 
done 24. Administration of a GPIIb / IIIa inhibitors 
is recommended in cases of coronary embolism, 
reported as tirofi ban 25, abciximab20, or eptifi bitide5. 
Even Steinwender et al.24 reported patients with 
coronary embolism of a thrombus in the left atrial 
appendage (LAA) in patients with atrial fi brillation 
who given bivalirudin after failing to provide 
effective results with antiplatelet therapy and low 
molecular weight heparin (LMWH) alone for 4 
days. The dose is an intravenous bolus of 0.75 mg / 
kg, followed by infusion of 1.75 mg/ kg/ hour for 48 
hours. Therapy with a long-term anticoagulant is 
needed to prevent recurrent embolic events 13, and 
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antiplatlet discontinued after coronary embolism 
improved 5. 
Conclusion
Women 25  years  o ld  w i th  STEMI 
presenting Killip IV, performed emergency 
coronary angiography procedures with results total 
occlusion of the distal LM caused by a thrombus, 
which suspected due to embolism of intraatrial 
thrombus due to mild-moderate mitral stenosis 
and severe regurgitation. Therapy of patients with 
coronary embolism due to intracardiac thrombus 
is recommended to administer double antiplatelet, 
heparin and GPIIb/IIIa inhibitors. Although 
there are no standard guidelines at this time. 
Transesophageal echocardiography examination 
is needed to ascertain whether any intraatrial 
thrombus in patients with mitral valve disease.
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